These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26405279)

  • 1. Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Taegtmeyer H; Beauloye C; Harmancey R; Hue L
    Diabetes; 2015 Oct; 64(10):e37. PubMed ID: 26405279
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Zaccardi F; Webb DR; Khunti K; Davies MJ
    Diabetes; 2015 Oct; 64(10):e35-6. PubMed ID: 26405278
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Comments on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Nolan CJ; Ruderman NB; Kahn SE; Pedersen O; Prentki M
    Diabetes; 2015 Oct; 64(10):e38-9. PubMed ID: 26405280
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.
    Nolan CJ; Ruderman NB; Kahn SE; Pedersen O; Prentki M
    Diabetes; 2015 Mar; 64(3):673-86. PubMed ID: 25713189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance - the body's defence against caloric intoxication?
    Methi T; Thorsby PM
    Tidsskr Nor Laegeforen; 2016 Jun; 136(11):1015-7. PubMed ID: 27325036
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Frontoni S
    Diabetes; 2013 Jan; 62(1):e1. PubMed ID: 23258917
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
    Kruszelnicka O; Rakowski T; Surdacki A
    Diabetes; 2013 Oct; 62(10):e23. PubMed ID: 24065801
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Straznicky NE; Lambert EA; Lambert GW
    Diabetes; 2013 Jan; 62(1):e2. PubMed ID: 23258918
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
    Tessari P
    Diabetes; 2013 Oct; 62(10):e24. PubMed ID: 24065802
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial insulin resistance, metabolic stress and autophagy in diabetes.
    Mellor KM; Bell JR; Ritchie RH; Delbridge LM
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):56-61. PubMed ID: 22804725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.
    Felber JP; Haesler E; Jéquier E
    Diabetologia; 1993 Dec; 36(12):1221-9. PubMed ID: 8307248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes: comment to Kayaniyil et al.
    Muscogiuri G; Sorice GP; Prioletta A; Policola C; Della Casa S; Pontecorvi A; Giaccari A
    Diabetes Care; 2010 Jul; 33(7):e99; author reply e100. PubMed ID: 20587719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of insulin resistance].
    Mäkinen S; Skrobuk P; Nguyen YH; Koistinen H
    Duodecim; 2013; 129(20):2115-22. PubMed ID: 24340711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium signalling and ER stress in insulin resistance and atherosclerosis.
    Ozcan L; Tabas I
    J Intern Med; 2016 Nov; 280(5):457-464. PubMed ID: 27739133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet Compensation in Metabolic Stress: Lessons from Animal Models.
    Singh H
    Curr Diabetes Rev; 2016; 12(4):315-321. PubMed ID: 26081679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance and oxidative stress].
    Andreeva-Gateva P
    Vutr Boles; 1999; 31(4):9-19. PubMed ID: 10989670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive sleep apnea: an unexpected cause of insulin resistance and diabetes.
    Morgenstern M; Wang J; Beatty N; Batemarco T; Sica AL; Greenberg H
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):187-204. PubMed ID: 24582098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance.
    Kahn BB
    Cell; 1998 Mar; 92(5):593-6. PubMed ID: 9506512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.